10X Genomics Inc
NASDAQ:TXG
Income Statement
Earnings Waterfall
10X Genomics Inc
Revenue
|
625.4m
USD
|
Cost of Revenue
|
-221.3m
USD
|
Gross Profit
|
404.1m
USD
|
Operating Expenses
|
-674.1m
USD
|
Operating Income
|
-270m
USD
|
Other Expenses
|
5.7m
USD
|
Net Income
|
-264.3m
USD
|
Income Statement
10X Genomics Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||
Revenue |
71
N/A
|
86
+22%
|
103
+19%
|
121
+18%
|
146
+21%
|
173
+18%
|
197
+14%
|
221
+13%
|
246
+11%
|
264
+7%
|
251
-5%
|
262
+4%
|
299
+14%
|
333
+11%
|
406
+22%
|
459
+13%
|
491
+7%
|
499
+2%
|
498
0%
|
504
+1%
|
516
+3%
|
536
+4%
|
568
+6%
|
591
+4%
|
619
+5%
|
625
+1%
|
|
Gross Profit | |||||||||||||||||||||||||||
Cost of Revenue |
(11)
|
(13)
|
(15)
|
(18)
|
(29)
|
(39)
|
(49)
|
(59)
|
(61)
|
(62)
|
(57)
|
(56)
|
(59)
|
(61)
|
(55)
|
(65)
|
(74)
|
(83)
|
(105)
|
(111)
|
(120)
|
(131)
|
(150)
|
(178)
|
(209)
|
(221)
|
|
Gross Profit |
61
N/A
|
74
+22%
|
88
+19%
|
104
+18%
|
118
+13%
|
134
+14%
|
148
+10%
|
162
+10%
|
185
+14%
|
202
+9%
|
194
-4%
|
206
+6%
|
240
+17%
|
272
+13%
|
350
+29%
|
394
+12%
|
416
+6%
|
417
+0%
|
393
-6%
|
393
0%
|
396
+1%
|
405
+2%
|
418
+3%
|
413
-1%
|
409
-1%
|
404
-1%
|
|
Operating Income | |||||||||||||||||||||||||||
Operating Expenses |
(79)
|
(102)
|
(118)
|
(144)
|
(228)
|
(232)
|
(251)
|
(259)
|
(216)
|
(250)
|
(270)
|
(337)
|
(772)
|
(793)
|
(842)
|
(838)
|
(469)
|
(501)
|
(529)
|
(553)
|
(564)
|
(584)
|
(594)
|
(646)
|
(665)
|
(674)
|
|
Selling, General & Administrative |
(47)
|
(59)
|
(71)
|
(77)
|
(88)
|
(94)
|
(106)
|
(119)
|
(131)
|
(154)
|
(166)
|
(183)
|
(200)
|
(205)
|
(230)
|
(241)
|
(258)
|
(267)
|
(278)
|
(289)
|
(298)
|
(315)
|
(324)
|
(333)
|
(336)
|
(342)
|
|
Research & Development |
(32)
|
(43)
|
(47)
|
(66)
|
(110)
|
(107)
|
(113)
|
(108)
|
(83)
|
(94)
|
(104)
|
(152)
|
(571)
|
(587)
|
(613)
|
(597)
|
(212)
|
(234)
|
(251)
|
(264)
|
(266)
|
(269)
|
(270)
|
(310)
|
(329)
|
(332)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
(31)
|
(31)
|
(32)
|
(32)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
|
Operating Income |
(18)
N/A
|
(28)
-50%
|
(29)
-7%
|
(40)
-36%
|
(111)
-178%
|
(98)
+11%
|
(103)
-5%
|
(98)
+6%
|
(31)
+69%
|
(48)
-55%
|
(76)
-60%
|
(131)
-72%
|
(532)
-306%
|
(521)
+2%
|
(492)
+6%
|
(444)
+10%
|
(52)
+88%
|
(84)
-60%
|
(137)
-63%
|
(161)
-18%
|
(168)
-5%
|
(178)
-6%
|
(176)
+1%
|
(233)
-33%
|
(256)
-10%
|
(270)
-5%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
3
|
6
|
10
|
13
|
15
|
15
|
18
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
(9)
|
(5)
|
|
Total Other Income |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
(1)
|
(1)
|
(3)
|
(4)
|
(0)
|
(1)
|
(1)
|
(0)
|
1
|
0
|
|
Pre-Tax Income |
(19)
N/A
|
(28)
-51%
|
(30)
-7%
|
(41)
-36%
|
(112)
-173%
|
(100)
+11%
|
(105)
-5%
|
(100)
+5%
|
(31)
+69%
|
(48)
-55%
|
(77)
-60%
|
(133)
-72%
|
(535)
-302%
|
(525)
+2%
|
(495)
+6%
|
(446)
+10%
|
(54)
+88%
|
(84)
-57%
|
(138)
-64%
|
(162)
-17%
|
(162)
0%
|
(170)
-5%
|
(167)
+2%
|
(219)
-31%
|
(249)
-14%
|
(257)
-3%
|
|
Net Income | |||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(8)
|
(8)
|
(9)
|
(9)
|
(5)
|
(5)
|
(4)
|
(6)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
|
Income from Continuing Operations |
(19)
|
(28)
|
(30)
|
(41)
|
(113)
|
(100)
|
(105)
|
(100)
|
(31)
|
(49)
|
(78)
|
(134)
|
(543)
|
(533)
|
(504)
|
(456)
|
(58)
|
(89)
|
(143)
|
(167)
|
(166)
|
(174)
|
(172)
|
(223)
|
(255)
|
(264)
|
|
Net Income (Common) |
(19)
N/A
|
(28)
-50%
|
(30)
-7%
|
(41)
-36%
|
(113)
-174%
|
(100)
+11%
|
(105)
-5%
|
(100)
+5%
|
(31)
+69%
|
(49)
-56%
|
(78)
-60%
|
(134)
-72%
|
(543)
-304%
|
(533)
+2%
|
(504)
+5%
|
(456)
+10%
|
(58)
+87%
|
(89)
-53%
|
(143)
-60%
|
(167)
-17%
|
(166)
+1%
|
(174)
-5%
|
(172)
+1%
|
(223)
-30%
|
(255)
-14%
|
(264)
-4%
|
|
EPS (Diluted) |
-0.2
N/A
|
-0.3
-50%
|
-0.32
-7%
|
-0.43
-34%
|
-1.2
-179%
|
-1.06
+12%
|
-1.12
-6%
|
-1.03
+8%
|
-0.32
+69%
|
-0.51
-59%
|
-0.8
-57%
|
-1.32
-65%
|
-5.37
-307%
|
-4.9
+9%
|
-4.58
+7%
|
-4.1
+10%
|
-0.53
+87%
|
-0.79
-49%
|
-1.26
-59%
|
-1.48
-17%
|
-1.46
+1%
|
-1.5
-3%
|
-1.49
+1%
|
-1.91
-28%
|
-2.18
-14%
|
-2.21
-1%
|